Ensysce Biosciences Inc (ENSC)
0.5705
0.00 (0.00%)
USD |
NASDAQ |
May 03, 13:20
Ensysce Biosciences 1 Year Total Returns (Daily): -84.15% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -84.15% |
May 01, 2024 | -83.48% |
April 30, 2024 | -84.22% |
April 29, 2024 | -84.19% |
April 26, 2024 | -84.75% |
April 25, 2024 | -85.10% |
April 24, 2024 | -84.18% |
April 23, 2024 | -84.79% |
April 22, 2024 | -85.26% |
April 19, 2024 | -87.69% |
April 18, 2024 | -86.41% |
April 17, 2024 | -86.54% |
April 16, 2024 | -83.82% |
April 15, 2024 | -82.97% |
April 12, 2024 | -80.09% |
April 11, 2024 | -79.18% |
April 10, 2024 | -78.15% |
April 09, 2024 | -77.97% |
April 08, 2024 | -77.97% |
April 05, 2024 | -76.32% |
April 04, 2024 | -76.65% |
April 03, 2024 | -82.92% |
April 02, 2024 | -83.33% |
April 01, 2024 | -83.95% |
March 28, 2024 | -88.62% |
Date | Value |
---|---|
March 27, 2024 | -87.65% |
March 26, 2024 | -87.34% |
March 25, 2024 | -87.65% |
March 22, 2024 | -86.73% |
March 21, 2024 | -88.16% |
March 20, 2024 | -88.03% |
March 19, 2024 | -88.66% |
March 18, 2024 | -88.93% |
March 15, 2024 | -89.09% |
March 14, 2024 | -89.51% |
March 13, 2024 | -88.92% |
March 12, 2024 | -89.19% |
March 11, 2024 | -88.69% |
March 08, 2024 | -89.45% |
March 07, 2024 | -90.08% |
March 06, 2024 | -88.65% |
March 05, 2024 | -87.42% |
March 04, 2024 | -88.33% |
March 01, 2024 | -83.99% |
February 29, 2024 | -84.11% |
February 28, 2024 | -84.39% |
February 27, 2024 | -84.72% |
February 26, 2024 | -85.69% |
February 23, 2024 | -86.14% |
February 22, 2024 | -86.11% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.30%
Minimum
Dec 28 2022
130.5%
Maximum
Feb 01 2021
-44.86%
Average
-71.85%
Median
Dec 08 2021
1 Year Total Returns (Daily) Benchmarks
Conmed Corp | -43.42% |
Relmada Therapeutics Inc | 40.38% |
Guardion Health Sciences Inc | 45.62% |
NeuroBo Pharmaceuticals Inc | -25.14% |
Processa Pharmaceuticals Inc | -82.99% |